Aug 19(Reuters) – The U.S. Food and Drug Administration approved Ultragenyx Pharmaceutical's gene therapy to treat a rare metabolic disorder, the company said on Wednesday. (Reporting by Padmanabhan
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
India’s Infrastructure Tender Opportunity and the Evolving Business Profile of VL Infraprojects
New Delhi [India], October 14: India’s infrastructure ecosystem continues to see substantial public investment across…
Ostapenko upsets Pegula in Wuhan; Swiatek, Muchova advance
VIDEO SHOWS: WTA 1000 WUHAN OPEN HIGHLIGHTS - JESSICA PEGULA V JELENA OSTAPENKO; MAGDALENA FRECH…
Failure to activate Hormuz fertilizer plan could trigger food crisis, UN official says
* UN-backed mechanism could start within 7-10 days of US-Iran agreement * Conflict has largely…
